α-Melanocyte-stimulating hormone-Induced eruptive nevi

Adela R. Cardones, James M Grichnik

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Synthetic peptides that target proopiomelanocortin receptors are being investigated as a novel and safe way to tan. It has been postulated that synthetic a-melanocyte-stimulating hormone (α-MSH) peptides may have protective effects against the development of melanoma because of their melanogenic activity. Their ultimate biological effect, however, especially in patients with dysplastic nevi or previous melanoma, has yet to be determined. Observations: A 40-year-old white man with a history of melanoma and multiple dysplastic nevi selfadministered synthetic α-MSH. He developed crops of new pigmented nevi, many of which had atypical clinical and histopathologic features. The preexisting nevi became darker and acquired growth features. After α- MSH use was discontinued, the nevi progressively lightened and lost their growth features. Conclusions: Synthetic α-MSH peptides can drive proliferation of neoplastic melanocytic cells in predisposed patients. This could present an increased risk for melanoma development.

Original languageEnglish
Pages (from-to)441-444
Number of pages4
JournalArchives of Dermatology
Volume145
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Melanocyte-Stimulating Hormones
Nevus
Melanoma
Dysplastic Nevus Syndrome
Peptides
Pigmented Nevus
Pro-Opiomelanocortin
Growth

ASJC Scopus subject areas

  • Dermatology

Cite this

α-Melanocyte-stimulating hormone-Induced eruptive nevi. / Cardones, Adela R.; Grichnik, James M.

In: Archives of Dermatology, Vol. 145, No. 4, 01.04.2009, p. 441-444.

Research output: Contribution to journalArticle

Cardones, Adela R. ; Grichnik, James M. / α-Melanocyte-stimulating hormone-Induced eruptive nevi. In: Archives of Dermatology. 2009 ; Vol. 145, No. 4. pp. 441-444.
@article{0c7645b44a4340a9b08f0bc9336e34be,
title = "α-Melanocyte-stimulating hormone-Induced eruptive nevi",
abstract = "Background: Synthetic peptides that target proopiomelanocortin receptors are being investigated as a novel and safe way to tan. It has been postulated that synthetic a-melanocyte-stimulating hormone (α-MSH) peptides may have protective effects against the development of melanoma because of their melanogenic activity. Their ultimate biological effect, however, especially in patients with dysplastic nevi or previous melanoma, has yet to be determined. Observations: A 40-year-old white man with a history of melanoma and multiple dysplastic nevi selfadministered synthetic α-MSH. He developed crops of new pigmented nevi, many of which had atypical clinical and histopathologic features. The preexisting nevi became darker and acquired growth features. After α- MSH use was discontinued, the nevi progressively lightened and lost their growth features. Conclusions: Synthetic α-MSH peptides can drive proliferation of neoplastic melanocytic cells in predisposed patients. This could present an increased risk for melanoma development.",
author = "Cardones, {Adela R.} and Grichnik, {James M}",
year = "2009",
month = "4",
day = "1",
doi = "10.1001/archdermatol.2008.623",
language = "English",
volume = "145",
pages = "441--444",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - α-Melanocyte-stimulating hormone-Induced eruptive nevi

AU - Cardones, Adela R.

AU - Grichnik, James M

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Background: Synthetic peptides that target proopiomelanocortin receptors are being investigated as a novel and safe way to tan. It has been postulated that synthetic a-melanocyte-stimulating hormone (α-MSH) peptides may have protective effects against the development of melanoma because of their melanogenic activity. Their ultimate biological effect, however, especially in patients with dysplastic nevi or previous melanoma, has yet to be determined. Observations: A 40-year-old white man with a history of melanoma and multiple dysplastic nevi selfadministered synthetic α-MSH. He developed crops of new pigmented nevi, many of which had atypical clinical and histopathologic features. The preexisting nevi became darker and acquired growth features. After α- MSH use was discontinued, the nevi progressively lightened and lost their growth features. Conclusions: Synthetic α-MSH peptides can drive proliferation of neoplastic melanocytic cells in predisposed patients. This could present an increased risk for melanoma development.

AB - Background: Synthetic peptides that target proopiomelanocortin receptors are being investigated as a novel and safe way to tan. It has been postulated that synthetic a-melanocyte-stimulating hormone (α-MSH) peptides may have protective effects against the development of melanoma because of their melanogenic activity. Their ultimate biological effect, however, especially in patients with dysplastic nevi or previous melanoma, has yet to be determined. Observations: A 40-year-old white man with a history of melanoma and multiple dysplastic nevi selfadministered synthetic α-MSH. He developed crops of new pigmented nevi, many of which had atypical clinical and histopathologic features. The preexisting nevi became darker and acquired growth features. After α- MSH use was discontinued, the nevi progressively lightened and lost their growth features. Conclusions: Synthetic α-MSH peptides can drive proliferation of neoplastic melanocytic cells in predisposed patients. This could present an increased risk for melanoma development.

UR - http://www.scopus.com/inward/record.url?scp=65349194406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349194406&partnerID=8YFLogxK

U2 - 10.1001/archdermatol.2008.623

DO - 10.1001/archdermatol.2008.623

M3 - Article

C2 - 19380666

AN - SCOPUS:65349194406

VL - 145

SP - 441

EP - 444

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 4

ER -